| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7f6c213006cea6b010748d9ae0912c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_676ffc9f24e838a98d06087cda9c5e9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5253f12e441d36a66f8ef6f322d9d76c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65522 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-08 |
| filingDate |
2008-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b46bc5b6d6ac6866af1230b476f8aa1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e36216cbd089b363531823ad8d3856dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbf0fcf93087ce4513f3979f62bf2a77 |
| publicationDate |
2008-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008221070-A1 |
| titleOfInvention |
Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| abstract |
Bone targeted compounds and methods are provided. Compounds can include a Bone Targeting Portion (R T ), having an affinity for bone; a Bone Active Portion (R A ) for interacting with and affecting bone; a Linking Portion (R L ) connecting the Bone Targeting Portion and the Bone Active Portion. The Bone Active Portion is derived from an estrogenic agent. Compounds can also include a Blocking Group (R P ) that reduces or eliminates the estrogenic activity of the Bone Active Portion. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8071575-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009118164-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547698-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020061577-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11459322-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11390621-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427576-B2 |
| priorityDate |
2007-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |